In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

The Outsourcing Dilemma

Executive Summary

The drug industry has accepted the need to outsource R&D--now, with sales productivity down, and the rising cost and risk of owning too much commercial infrastructure, why not outsource more of the sales effort, too? Big and small pharmas resist the idea but will eventually have to accept it--junior partners in licensing deals are insisting on roles in selling their own products, and Big Pharma must investigate cost-saving solutions.
Advertisement

Related Content

BMS Deals Diabetes Drugs, Solidifies Specialist Stance
BMS Deals Diabetes Drugs, Solidifies Specialist Stance
Pharmaceutical Strategic Alliances 2006: Forcing Externalization at Big Pharma
Generic Plavix: As Bristol Swoons, Broad Implications
Generic Plavix: As Bristol Swoons, Broad Implications
Small Companies Can Too Co-Promote
A Riskier, But Perhaps More Profitable, CSO Business
CV Therapeutics: Co-Promoting Without Pharma
PDI Sticks to Contract Sales

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

IV002824

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel